Entourage_logo (002).jpg
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
May 28, 2024 07:34 ET | Entourage Health Corp.
Total revenue of $16.4 million represents a 9% increase year-over-year and a 23% sequential increase from Q4 2023.Gross profit before fair value changes improved by 92% year-over-year, leading to a...
Entourage_logo (002).jpg
Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28
May 14, 2024 07:30 ET | Entourage Health Corp.
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage_logo (002).jpg
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
April 30, 2024 07:13 ET | Entourage Health Corp.
Gross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A...
Entourage_logo (002).jpg
Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30
August 09, 2023 07:45 ET | Entourage Health Corp.
TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage_logo (002).jpg
Entourage Health Reports First Quarter 2023 Financial Results
May 30, 2023 07:48 ET | Entourage Health Corp.
Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022.Net Revenue in medical accounted for $6.0 million, a 61% sequential increase over Q4 2022.Color Cannabis...
Entourage_logo (002).jpg
Entourage Health to Host First Quarter 2023 Earnings Conference Call
May 15, 2023 07:30 ET | Entourage Health Corp.
Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares...
Entourage_logo (002).jpg
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
May 01, 2023 19:52 ET | Entourage Health Corp.
Record net medical revenue of $17.4 million for 2022, representing 16% growthEntourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022Upsized...
Entourage_logo (002).jpg
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results
April 21, 2023 16:00 ET | Entourage Health Corp.
TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Entourage_logo (002).jpg
Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28
April 14, 2023 07:35 ET | Entourage Health Corp.
TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Entourage_logo (002).jpg
Entourage Health Corp Issues Deferred Share Units and Enters into Shares-for-Debt Agreements
April 03, 2023 07:30 ET | Entourage Health Corp.
TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...